Excellergy

Developer of trifunctional effector cell response inhibitors for allergic diseases

placePalo Alto, California, United States calendar_todayFounded 2020 language excellergy.com

Innovation

2 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 44 times.

YearFilings
20252

Investor mix

3 investors on record; lead investors include Samsara BioCapital.

Investor typeCountShare
Venture capital3100%
Coming soon